Richard Maiman, MD | |
535 Plandome Rd, Manhasset, NY 11030-1974 | |
(516) 627-6288 | |
(516) 627-6188 |
Full Name | Richard Maiman |
---|---|
Gender | Male |
Speciality | Urology |
Experience | 9 Years |
Location | 535 Plandome Rd, Manhasset, New York |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1750776969 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | 303752 (New York) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Francis Hospital - The Heart Center | Roslyn, NY | Hospital |
North Shore University Hospital | Manhasset, NY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Integrated Medical Professionals Pllc | 6406868462 | 85 |
News Archive
Most healthy cells rely on a complicated process to produce the fuel ATP. Knowing how ATP is produced by the cell's energy storehouse - the mitochondria - is important for understanding a cell's normal state, as well as what happens when things go wrong, for example in cancer, cardiovascular disease, neurodegeneration, and many rare disorders of the mitochondria.
"These new guidelines were formulated by a group of leading experts in child psychiatry and are the most up-to-date and comprehensive set of guidelines for the treatment of children and adolescents with bipolar disorder," said Dr. Kowatch. "They represent a major step towards practicing evidence-based medicine in this difficult to treat group of patients.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration (FDA) has notified the company of the confirmed scheduling of an Endocrinologic and Metabolic Drugs Advisory Committee meeting on September 16, 2010, for the review of the lorcaserin New Drug Application (NDA). Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
For years, patients with an eye disease called keratoconus have had little to no hope of continuing to see well without glasses or contacts, and a portion of them had a high risk corneal transplant in their future. Keratoconus is an eye disease that causes the cornea (the clear covering on the eye) to become thin and steep over time. Patients with keratoconus can wear special contact lenses or in some cases glasses. Many of them lose the ability to see well even with corrective eye wear.
Washington State University researchers have found a way to make food taste salty but with less of the sodium chloride tied to poor health.
› Verified 9 days ago
Entity Name | Metropolitan Lithotriptor Associates Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1891027967 PECOS PAC ID: 5193615730 Enrollment ID: O20040317001512 |
News Archive
Most healthy cells rely on a complicated process to produce the fuel ATP. Knowing how ATP is produced by the cell's energy storehouse - the mitochondria - is important for understanding a cell's normal state, as well as what happens when things go wrong, for example in cancer, cardiovascular disease, neurodegeneration, and many rare disorders of the mitochondria.
"These new guidelines were formulated by a group of leading experts in child psychiatry and are the most up-to-date and comprehensive set of guidelines for the treatment of children and adolescents with bipolar disorder," said Dr. Kowatch. "They represent a major step towards practicing evidence-based medicine in this difficult to treat group of patients.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration (FDA) has notified the company of the confirmed scheduling of an Endocrinologic and Metabolic Drugs Advisory Committee meeting on September 16, 2010, for the review of the lorcaserin New Drug Application (NDA). Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
For years, patients with an eye disease called keratoconus have had little to no hope of continuing to see well without glasses or contacts, and a portion of them had a high risk corneal transplant in their future. Keratoconus is an eye disease that causes the cornea (the clear covering on the eye) to become thin and steep over time. Patients with keratoconus can wear special contact lenses or in some cases glasses. Many of them lose the ability to see well even with corrective eye wear.
Washington State University researchers have found a way to make food taste salty but with less of the sodium chloride tied to poor health.
› Verified 9 days ago
Entity Name | Integrated Medical Professionals Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346203536 PECOS PAC ID: 6406868462 Enrollment ID: O20060613000088 |
News Archive
Most healthy cells rely on a complicated process to produce the fuel ATP. Knowing how ATP is produced by the cell's energy storehouse - the mitochondria - is important for understanding a cell's normal state, as well as what happens when things go wrong, for example in cancer, cardiovascular disease, neurodegeneration, and many rare disorders of the mitochondria.
"These new guidelines were formulated by a group of leading experts in child psychiatry and are the most up-to-date and comprehensive set of guidelines for the treatment of children and adolescents with bipolar disorder," said Dr. Kowatch. "They represent a major step towards practicing evidence-based medicine in this difficult to treat group of patients.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration (FDA) has notified the company of the confirmed scheduling of an Endocrinologic and Metabolic Drugs Advisory Committee meeting on September 16, 2010, for the review of the lorcaserin New Drug Application (NDA). Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
For years, patients with an eye disease called keratoconus have had little to no hope of continuing to see well without glasses or contacts, and a portion of them had a high risk corneal transplant in their future. Keratoconus is an eye disease that causes the cornea (the clear covering on the eye) to become thin and steep over time. Patients with keratoconus can wear special contact lenses or in some cases glasses. Many of them lose the ability to see well even with corrective eye wear.
Washington State University researchers have found a way to make food taste salty but with less of the sodium chloride tied to poor health.
› Verified 9 days ago
Entity Name | Hudson Valley Lithotripsy Associates, P.c. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1437242781 PECOS PAC ID: 4183078603 Enrollment ID: O20231002001672 |
News Archive
Most healthy cells rely on a complicated process to produce the fuel ATP. Knowing how ATP is produced by the cell's energy storehouse - the mitochondria - is important for understanding a cell's normal state, as well as what happens when things go wrong, for example in cancer, cardiovascular disease, neurodegeneration, and many rare disorders of the mitochondria.
"These new guidelines were formulated by a group of leading experts in child psychiatry and are the most up-to-date and comprehensive set of guidelines for the treatment of children and adolescents with bipolar disorder," said Dr. Kowatch. "They represent a major step towards practicing evidence-based medicine in this difficult to treat group of patients.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration (FDA) has notified the company of the confirmed scheduling of an Endocrinologic and Metabolic Drugs Advisory Committee meeting on September 16, 2010, for the review of the lorcaserin New Drug Application (NDA). Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
For years, patients with an eye disease called keratoconus have had little to no hope of continuing to see well without glasses or contacts, and a portion of them had a high risk corneal transplant in their future. Keratoconus is an eye disease that causes the cornea (the clear covering on the eye) to become thin and steep over time. Patients with keratoconus can wear special contact lenses or in some cases glasses. Many of them lose the ability to see well even with corrective eye wear.
Washington State University researchers have found a way to make food taste salty but with less of the sodium chloride tied to poor health.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Richard Maiman, MD 340 Broadhollow Rd, Farmingdale, NY 11735-4807 Ph: (516) 931-0041 | Richard Maiman, MD 535 Plandome Rd, Manhasset, NY 11030-1974 Ph: (516) 627-6288 |
News Archive
Most healthy cells rely on a complicated process to produce the fuel ATP. Knowing how ATP is produced by the cell's energy storehouse - the mitochondria - is important for understanding a cell's normal state, as well as what happens when things go wrong, for example in cancer, cardiovascular disease, neurodegeneration, and many rare disorders of the mitochondria.
"These new guidelines were formulated by a group of leading experts in child psychiatry and are the most up-to-date and comprehensive set of guidelines for the treatment of children and adolescents with bipolar disorder," said Dr. Kowatch. "They represent a major step towards practicing evidence-based medicine in this difficult to treat group of patients.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration (FDA) has notified the company of the confirmed scheduling of an Endocrinologic and Metabolic Drugs Advisory Committee meeting on September 16, 2010, for the review of the lorcaserin New Drug Application (NDA). Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
For years, patients with an eye disease called keratoconus have had little to no hope of continuing to see well without glasses or contacts, and a portion of them had a high risk corneal transplant in their future. Keratoconus is an eye disease that causes the cornea (the clear covering on the eye) to become thin and steep over time. Patients with keratoconus can wear special contact lenses or in some cases glasses. Many of them lose the ability to see well even with corrective eye wear.
Washington State University researchers have found a way to make food taste salty but with less of the sodium chloride tied to poor health.
› Verified 9 days ago
Joph Steckel, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 535 Plandome Rd, Manhasset, NY 11030 Phone: 516-627-6188 Fax: 516-627-9397 | |
Dr. Raymond Charles Sultan, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 535 Plandome Rd, Manhasset, NY 11030 Phone: 516-627-6188 Fax: 516-627-9397 | |
Dr. Ilan Joseph Safir, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 535 Plandome Rd Frnt 3, Manhasset, NY 11030 Phone: 516-627-6188 Fax: 516-627-9397 | |
Leonard Mondschein, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 535 Plandome Rd, Manhasset, NY 11030 Phone: 516-627-6188 | |
Dr. Dimitri Nikitas Kessaris, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 315 East Shore Rd, Manhasset, NY 11030 Phone: 516-487-5577 Fax: 516-487-2947 | |
Lawrence A Fish, Urology Medicare: Not Enrolled in Medicare Practice Location: 535 Plandome Rd, Manhasset, NY 11030 Phone: 516-627-6618 Fax: 516-627-9397 |